Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST
Abroad (travel likely)Recruiting
Conditions
Gastrointestinal Stromal Tumors
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Xiangya Hospital, Central South University, Changsha, Hunan, China
Contact: Principal Investigator (Heli Liu, Ph.D)